AR015962A1 - LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS. - Google Patents

LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.

Info

Publication number
AR015962A1
AR015962A1 ARP980105093A ARP980105093A AR015962A1 AR 015962 A1 AR015962 A1 AR 015962A1 AR P980105093 A ARP980105093 A AR P980105093A AR P980105093 A ARP980105093 A AR P980105093A AR 015962 A1 AR015962 A1 AR 015962A1
Authority
AR
Argentina
Prior art keywords
preparation
procedure
medicinal product
lantibiotic
actagardine
Prior art date
Application number
ARP980105093A
Other languages
English (en)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR015962A1 publication Critical patent/AR015962A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10Peptides having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente se refiere a un nuevo lantibiotico con la formula NH2-R-actagardina, significando NH2-R el resto del aminoácido alanina, que se forma durantela fermentacion por el microorganismo Actinoplanes liguriae DSM 11797 o Actinoplanesgarbadiensis DSM 11796, a derivados químicos del lantibiotico, a unprocedimiento para su preparacion y al empleo de los lantibioticos como medicamento.
ARP980105093A 1997-10-15 1998-10-13 LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS. AR015962A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745583A DE19745583A1 (de) 1997-10-15 1997-10-15 Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
AR015962A1 true AR015962A1 (es) 2001-05-30

Family

ID=7845627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105093A AR015962A1 (es) 1997-10-15 1998-10-13 LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.

Country Status (15)

Country Link
US (1) US6022851A (es)
EP (1) EP0916680B1 (es)
JP (1) JP3684432B2 (es)
KR (1) KR100482402B1 (es)
CN (1) CN1165547C (es)
AR (1) AR015962A1 (es)
AT (1) ATE258558T1 (es)
AU (1) AU739516C (es)
BR (1) BRPI9803914B1 (es)
CA (1) CA2250630C (es)
DE (2) DE19745583A1 (es)
DK (1) DK0916680T3 (es)
ES (1) ES2213862T3 (es)
HK (1) HK1020739A1 (es)
PT (1) PT916680E (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
EP1908774A1 (en) * 2006-10-06 2008-04-09 sanofi-aventis Antibacterial and antiviral peptides from Actinomadura namibiensis
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
KR20110086582A (ko) * 2008-11-24 2011-07-28 센티넬라 파마세티컬즈, 인크. 항균활성이 강화된 란티바이오틱 카르복시아미드 유도체
GB0900599D0 (en) * 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
CN102348718B (zh) 2009-01-14 2015-06-03 诺瓦克塔生物系统有限公司 去氧阿肽加定衍生物
EP2393829A1 (en) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) * 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US20140094402A1 (en) * 2011-03-30 2014-04-03 Sentinella Pharmaceuticals, Inc. Lantibiotic NAI-802, Pharmaceutically Acceptable Salts, Compositions and Uses Thereof
CA2941080A1 (en) * 2014-03-25 2015-10-01 Lanthiopep B.V. Cyclic apelin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470407A (en) * 1974-07-27 1977-04-14 Lepetit Spa Antibiotic substances
GB8507528D0 (en) * 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
CA2250630C (en) 2008-07-15
BRPI9803914B1 (pt) 2016-11-01
AU739516C (en) 2002-05-02
AU8926198A (en) 1999-05-06
DE19745583A1 (de) 1999-04-22
EP0916680A2 (de) 1999-05-19
JPH11193299A (ja) 1999-07-21
ES2213862T3 (es) 2004-09-01
JP3684432B2 (ja) 2005-08-17
KR100482402B1 (ko) 2005-08-31
EP0916680B1 (de) 2004-01-28
KR19990037179A (ko) 1999-05-25
CN1165547C (zh) 2004-09-08
BR9803914A (pt) 2000-03-28
DK0916680T3 (da) 2004-05-24
DE59810658D1 (de) 2004-03-04
EP0916680A3 (de) 2001-10-17
ATE258558T1 (de) 2004-02-15
CN1221752A (zh) 1999-07-07
US6022851A (en) 2000-02-08
PT916680E (pt) 2004-06-30
AU739516B2 (en) 2001-10-11
CA2250630A1 (en) 1999-04-15
HK1020739A1 (en) 2000-05-19

Similar Documents

Publication Publication Date Title
AR015962A1 (es) LANTIBIoTICO RELACIONADO CON ACTAGARDINA, PROCEDIMIENTO PARA SU PREPARACIoN, MEDICAMENTO, PROCEDIMIENTO PARA LA PREPARACIoN DE UN MEDICAMENTO Y EMPLEO DEL MISMO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA ENFERMEDADES INFECCIOSAS BACTERIANAS.
ES2178657T3 (es) Derivados lipopeptidos, procedimiento para su preparacion y su empleo.
ES2130265T3 (es) Region de union al receptor de la toxina difterica.
ES2178779T3 (es) Nuevas amidas de acidos de piridil alcanos como agentes citoestaticos e inmunosupresores.
HUP0101817A2 (hu) 15 tagú laktám ketolidok és ezeket tartalmazó antibakteriális hatású gyógyszerkészítmények
ES2064398T3 (es) Un nuevo antibiotico, mersacidina, un procedimiento para su preparacion y su utilizacion como medicamento.
DK165120C (da) Basiske monokarboxyamidderivater af actagardin, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende derivaterne
EA200100700A1 (ru) Гены и белки и их применение
ES2135023T3 (es) Utilizacion de un decapeptido con actividad de tipo benzodiazepina para la preparacion de medicamentos y complementos alimentarios.
DK0552106T3 (da) Peptider med antagonistaktivitet over for bradykinin
ES508985A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
EP2013234B1 (en) Peptide compound with biological activity, its preparation and its application
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
ES2175582T3 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen.
UY28592A1 (es) Derivados de 2-fenilbenzofurano, un procedimiento para su preparación y su uso
GR3031254T3 (en) Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
BR0207953A (pt) Derivados de caloporosida, processos para a sua preparação e sua aplicação
Floc'h et al. Immunopotentiating activities of a low molecular weight lipopetide, RP 56 142—Studies in infectious models
ES2038244T3 (es) Procedimiento para preparar un nuevo antibiotico, fumifungina, y su empleo como medicamento.
GB1224658A (en) Cyclic decapeptides
ATE305941T1 (de) Impfstoff
AP1684A (en) Dithiocarbamate derivatives and their use as antibacterial agents.
TH126305A (th) อนุพันธุ์เพพไทด์ vapeehptllteaplnpk ที่มีการกระตุ้นทางชีวภาพ
ES2173044B1 (es) Derivados de glicina, n-(n-l-gamma-glutamil-3-(nitrosotio)-l-valil) y sus aplicaciones.
ES2094734T3 (es) Derivados de cefalosporinas y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG Grant, registration